Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / Class A Stock
-
Shares outstanding
-
115M
-
Number of holders
-
301
-
Total 13F shares, excl. options
-
66.3M
-
Shares change
-
-1.02M
-
Total reported value, excl. options
-
$3.9B
-
Value change
-
-$37.5M
-
Put/Call ratio
-
1.12
-
Number of buys
-
153
-
Number of sells
-
-111
-
Price
-
$58.88
Significant Holders of GLOBUS MEDICAL INC - Class A Stock (GMED) as of Q4 2019
332 filings reported holding GMED - GLOBUS MEDICAL INC - Class A Stock as of Q4 2019.
GLOBUS MEDICAL INC - Class A Stock (GMED) has 301 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 66.3M shares
of 115M outstanding shares and own 57.51% of the company stock.
Largest 10 shareholders include BlackRock Inc. (9.62M shares), VANGUARD GROUP INC (7.29M shares), JANUS HENDERSON GROUP PLC (6.89M shares), WELLINGTON MANAGEMENT GROUP LLP (3.82M shares), STATE STREET CORP (2.54M shares), Van Berkom & Associates Inc. (1.47M shares), MANUFACTURERS LIFE INSURANCE COMPANY, THE (1.45M shares), GW&K Investment Management, LLC (1.41M shares), Standard Life Aberdeen plc (1.31M shares), and NORTHERN TRUST CORP (1.23M shares).
This table shows the top 301 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.